$ECOR
electroCore, Inc.

2023 Q2 Form 10-Q Financial Statement

#000121390023035987 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $3.551M $2.780M $1.899M
YoY Change 64.63% 46.39% 57.72%
Cost Of Revenue $585.0K $458.0K $360.0K
YoY Change 63.41% 27.22% -1.1%
Gross Profit $2.966M $2.322M $1.539M
YoY Change 64.87% 50.88% 83.21%
Gross Profit Margin 83.53% 83.53% 81.04%
Selling, General & Admin $6.799M $6.710M $6.186M
YoY Change 8.3% 8.47% 8.05%
% of Gross Profit 229.23% 288.98% 401.95%
Research & Development $1.155M $1.809M $934.0K
YoY Change -13.87% 93.68% 87.17%
% of Gross Profit 38.94% 77.91% 60.69%
Depreciation & Amortization $322.0K $122.0K $106.0K
YoY Change 128.37% 15.09% 10.42%
% of Gross Profit 10.86% 5.25% 6.89%
Operating Expenses $7.954M $8.519M $7.120M
YoY Change 4.4% 19.65% 14.4%
Operating Profit -$4.988M -$6.197M -$5.581M
YoY Change -14.3% 11.04% 3.66%
Interest Expense $2.250K $2.035K $4.000K
YoY Change -94.08% -49.13%
% of Operating Profit
Other Income/Expense, Net $85.00K $119.0K -$1.000K
YoY Change 123.68% -12000.0%
Pretax Income -$4.903M -$6.078M -$5.582M
YoY Change -15.2% 8.89% 3.68%
Income Tax -$211.0K
% Of Pretax Income
Net Earnings -$4.903M -$5.867M -$5.582M
YoY Change -8.13% 5.11% 3.68%
Net Earnings / Revenue -138.07% -211.04% -293.94%
Basic Earnings Per Share -$1.03 -$1.24 -$1.20
Diluted Earnings Per Share -$1.03 -$1.24 -$78.98K
COMMON SHARES
Basic Shares Outstanding 4.749M shares 4.742M shares 70.72M shares
Diluted Shares Outstanding 4.751M shares 4.743M shares 4.652M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.442M $11.91M $29.88M
YoY Change -67.94% -60.15% 17.4%
Cash & Equivalents $8.442M $11.91M $29.88M
Short-Term Investments
Other Short-Term Assets $356.0K $775.0K $671.0K
YoY Change -25.83% 15.5% -25.44%
Inventory $2.368M $2.478M $1.577M
Prepaid Expenses
Receivables $238.0K $213.0K $364.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.40M $15.37M $32.49M
YoY Change -60.84% -52.69% 17.76%
LONG-TERM ASSETS
Property, Plant & Equipment $114.0K $34.00K $122.0K
YoY Change 15.15% -72.13% -44.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $819.0K $891.0K $636.0K
YoY Change 7.62% 40.09% -15.98%
Total Long-Term Assets $2.818M $2.926M $4.687M
YoY Change -35.32% -37.57% -23.88%
TOTAL ASSETS
Total Short-Term Assets $11.40M $15.37M $32.49M
Total Long-Term Assets $2.818M $2.926M $4.687M
Total Assets $14.22M $18.30M $37.18M
YoY Change -57.52% -50.78% 10.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.284M $2.001M $2.235M
YoY Change 11.25% -10.47% 5.91%
Accrued Expenses $4.210M $3.770M $2.384M
YoY Change 19.5% 58.14% 10.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.575M $5.848M $4.683M
YoY Change 16.5% 24.88% -12.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $583.0K $605.0K $682.0K
YoY Change -12.2% -11.29% -24.22%
Total Long-Term Liabilities $583.0K $605.0K $682.0K
YoY Change -12.2% -11.29% -62.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.575M $5.848M $4.683M
Total Long-Term Liabilities $583.0K $605.0K $682.0K
Total Liabilities $7.158M $6.453M $5.365M
YoY Change 13.47% 20.28% -24.25%
SHAREHOLDERS EQUITY
Retained Earnings -$157.1M -$152.2M -$129.8M
YoY Change 16.29% 17.29% 15.5%
Common Stock $164.3M $164.1M $161.5M
YoY Change 1.22% 1.57% 333038.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.064M $11.85M $31.82M
YoY Change
Total Liabilities & Shareholders Equity $14.22M $18.30M $37.18M
YoY Change -57.52% -50.78% 10.17%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.903M -$5.867M -$5.582M
YoY Change -8.13% 5.11% 3.68%
Depreciation, Depletion And Amortization $322.0K $122.0K $106.0K
YoY Change 128.37% 15.09% 10.42%
Cash From Operating Activities -$3.312M -$5.860M -$4.780M
YoY Change 2.1% 22.59% 15.01%
INVESTING ACTIVITIES
Capital Expenditures $91.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$91.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -3.312M -$5.860M -$4.780M
Cash From Investing Activities -91.00K
Cash From Financing Activities 0.000
Net Change In Cash -3.403M -$5.804M -$4.807M
YoY Change 4.9% 20.74% -199.69%
FREE CASH FLOW
Cash From Operating Activities -$3.312M -$5.860M -$4.780M
Capital Expenditures $91.00K
Free Cash Flow -$3.403M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38538
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
electroCore, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3454976
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Forge Way
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 205
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockaway
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07866
CY2023Q1 dei City Area Code
CityAreaCode
(973)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
290-0097
CY2023Q1 dei Trading Symbol
TradingSymbol
ECOR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4749221 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11908000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17712000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
213000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
401000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2478000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1982000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
525000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
828000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
15374000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21173000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
1451000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2194000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001560258
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
777000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
122000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
550000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
891000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
774000 usd
CY2022Q4 us-gaap Assets
Assets
24756000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2001000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2129000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3770000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5848000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7045000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
605000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
625000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6453000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7670000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
71173 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
71173 shares
CY2022Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.001
CY2023Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
usd
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4745781 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4745781 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4744886 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4744886 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164092000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
163520000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152237000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146370000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11847000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17086000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18300000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24756000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2780000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
458000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
360000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2322000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1539000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1809000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
934000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6710000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6186000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7120000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6197000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5581000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
119000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
4000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
119000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6078000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5582000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5867000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5582000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.2
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.2
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4743000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4743000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4652000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4652000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5867000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5582000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
56000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
56000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5811000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5609000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17086000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5867000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
56000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
572000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11847000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36582000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5582000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
777000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31750000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5867000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5582000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
572000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
106000 usd
CY2023Q1 ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
15000 usd
CY2022Q1 ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
13000 usd
CY2022Q4 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
944000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
75000 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-188000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-75000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-399000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-303000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-252000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-128000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
692000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1072000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1497000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-17000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-15000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5860000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4780000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-27000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5804000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4807000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17962000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34689000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12158000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29882000 usd
CY2023Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
211000 usd
CY2022Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
2000 usd
CY2023Q1 ecor Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2 subsidiary
CY2023Q1 us-gaap Debt Instrument Convertible Stock Price Trigger
DebtInstrumentConvertibleStockPriceTrigger
1
CY2023Q1 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
10
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
CY2023Q1 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
2480000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_Q9Y8OSSSWG00000000000000000000b"> <table cellpadding="0" cellspacing="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> (c) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> Use of Estimates </span></p> </td> </tr> </tbody> </table> </div> </div> <p style="margin: 6pt 0pt 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-align: justify; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: 1.2; margin: 6pt 0in 0in; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, trade credits, rebates, co-payment assistance and sales returns, valuation of inventory, estimated useful life of licensed products and cloud computing arrangements, stock compensation, incremental borrowing rate and contingencies.   </span></span></p> </div> </div> </div>
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11908000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12158000 usd
CY2023Q1 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
871000 usd
CY2023Q1 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
0 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.645 pure
CY2023Q1 ecor Federal Supply Schedule Expire Date
FederalSupplyScheduleExpireDate
2024-01-15
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2780000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1899000 usd
CY2023Q1 ecor Payment Term For Customers
PaymentTermForCustomers
P30D
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
314000 usd
CY2022Q4 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
2879000 usd
CY2023Q1 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
578000 usd
CY2022Q4 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
353000 usd
CY2023Q1 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
3929000 usd
CY2022Q4 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
4176000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
1451000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2194000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2478000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1982000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
738000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
668000 usd
CY2023Q1 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
500000 usd
CY2022Q4 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
100000 usd
CY2023Q1 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
1000000 usd
CY2022Q4 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
2100000 usd
CY2022Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
550000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
605000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
682000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2023Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
123000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
168000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
171000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
161000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
157000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
216000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
682000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
996000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039 pure
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
610000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
524000 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
880000 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2042000 usd
CY2023Q1 ecor Accrued Legal Fees Litigation Expense
AccruedLegalFeesLitigationExpense
1001000 usd
CY2022Q4 ecor Accrued Legal Fees Litigation Expense
AccruedLegalFeesLitigationExpense
1001000 usd
CY2023Q1 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
usd
CY2022Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
264000 usd
CY2023Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
534000 usd
CY2022Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
534000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
301000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
162000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
133000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
17000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
152000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
265000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
87900 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2035 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
561000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
527000 shares
CY2023Q1 us-gaap Proceeds From Operating Activities
ProceedsFromOperatingActivities
211000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.1
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.14 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
440000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.65
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
6000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
437000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.74
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
284000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
75.84
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
572000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
777000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
23200000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.50 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.46
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.84 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2020Q3 ecor Number Of Investors As Defendants
NumberOfInvestorsAsDefendants
2 investors

Files In Submission

Name View Source Status
ecor-20230331_cal.xml Edgar Link unprocessable
0001213900-23-035987-index-headers.html Edgar Link pending
0001213900-23-035987-index.html Edgar Link pending
0001213900-23-035987.txt Edgar Link pending
0001213900-23-035987-xbrl.zip Edgar Link pending
ecor-20230331.htm Edgar Link pending
ecor-20230331.xsd Edgar Link pending
ex101_1.htm Edgar Link pending
ex311_2.htm Edgar Link pending
ex312_3.htm Edgar Link pending
ex321_4.htm Edgar Link pending
ex322_5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ecor-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ecor-20230331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ecor-20230331_def.xml Edgar Link unprocessable
ecor-20230331_lab.xml Edgar Link unprocessable